Introduction
============

In an era of tremendous technological capabilities, insufficient accessibility to nutritious food, a primary human need, still affects over two billion people on a global scale ([@B13]; [@B82]). Though approximately 800 million people endure energy deficit due to inadequate amounts of calories in their diet ([@B84]; [@B59]), the relative abundance of undernourishment has dropped to almost half in the last 25 years. Unfortunately, the degree of undernourishment witnessed over the last decades has recently passed a minimum, as undernourishment is estimated to have affected 815 million people in 2016, as opposed to 777 million in 2015 ([@B59]). The general trend of a decrease in global undernourishment can be mainly attributed to yield improvement of important staple crops such as rice, maize and wheat, which has more than doubled since 1960 ([@B116]). Unfortunately, caloric malnutrition represents only a portion of the food-related burden of diseases, as micronutrient malnutrition (MNM) is present in over one--fourth of the world's population ([@B13]; [@B20]; [@B44]).

Micronutrient malnutrition comprises shortage of dietary micronutrients, including minerals (iron, zinc, iodine, selenium, etc.) as well as vitamins ([@B13]). Micronutrient malnourishment, commonly referred to as the "hidden hunger," is known to induce diseases and disorders in many populations, not particularly confined to the developing world. Pregnant women and young children are most vulnerable for MNM, often resulting in death ([@B13]; [@B46]; [@B200]; [@B44]). MNM can be considered an urgent global concern, persistent in many populations and remaining largely hidden ([@B160]). Anemia, a condition of suboptimal hemoglobin level ([@B166]), illustrates the disastrous impact of combined micronutrient shortage on human physiology, as its occurrence has been linked with deficiency in iron ([@B31]), pro-vitamin A ([@B168]; [@B198]), thiamin (vitamin B1) ([@B62]), pyridoxine (vitamin B6) ([@B36]; [@B92]) and folate (vitamin B9) ([@B131]). Anemia is held responsible for almost 2 million deaths of children under 5 years old on a yearly basis ([@B166]), and is estimated to affect more than 2 billion people globally. It is estimated that half of the cases of anemia could be attributed to deficiency in one or more micronutrients, though primary factors are iron and folate shortage ([@B166]).

High incidence of micronutrient deficiencies are, in many cases, related to monotonous diets, largely consisting of energy rich, starchy staples ([@B20]; [@B44]). These crops including wheat, rice, potato, cassava, corn and plantain have the tendency to contain inadequate levels of vitamins and therefore expose the population, consuming massive amounts of these staples, to the risk of vitamin deficiencies (**Table [1](#T1){ref-type="table"}**). This is a downside of the cheap supply of energy rich staples, which enabled the aforementioned decrease in caloric malnourishment.

###### 

Vitamin content of six major staple crops.

                                          RDA^1^   Wheat (*Triticum aestivum*) Soft, white   Rice (*Oryza sativa*) White, long-grain, regular, raw   Potato (*Solanum tuberosum*) Flesh and skin, raw   Cassava (*Manihot esculenta*) Raw        Corn (*Zea mays*) Sweet, white, raw   Plantain (*Musa* sp.) Raw
  --------------------------------------- -------- ----------------------------------------- ------------------------------------------------------- -------------------------------------------------- ---------------------------------------- ------------------------------------- ---------------------------
  B1 (mg)                                 1.4      0.41 (sufficient)                         0.07 (5)                                                0.081 (4)                                          0.087 (3)                                0.2 (2)                               0.052 (8)
  B6 (mg)                                 2        0.378 (sufficient)                        0.164 (3)                                               0.298 (2)                                          0.088 (4)                                0.055 (9)                             0.299 (2)
  B9 (μg)                                 600      41 (3)                                    8 (16)                                                  15 (8)                                             27 (4)                                   46 (3)                                22 (8)
  Highest consumption (g/capita.day)^2^   /        609 (Azerbaijan)                          470^3^ (Bangladesh)                                     502 (Belarus)                                      678 (Democratic Republic of the Congo)   434 (Lesotho)                         350 (Ghana)

Vitamin content data were retrieved from the USDA database (

USDA, 2016

). RDA data were retrieved from (

Trumbo et al., 2001

). Values represent vitamin content of 100 g fresh edible portion of each crop. Fold enhancement needed to reach the RDA of the corresponding vitamin upon consuming the highest average national serving, is indicated between brackets. Data on staple crop consumption are derived from FAOSTAT (

FAOSTAT, 2017

).

1

Highest recommended daily allowance (RDA).

2

In 2013.

3

Milled equivalent.

Given the observation that MNM have a detrimental effect on global human health, there is a great need to strongly reduce these deficiencies, also stated in the Copenhagen consensus, where micronutrient interventions were ranked as the number one priority, related to Sustainable Development Goal 2 (SDG2), requiring great global investment ([@B39]). Fortunately, there are several means to combat MNM in an effective way, which can be divided in education, supplementation and biofortification. Behavioral interventions, consisting of educational efforts encouraging dietary diversification, are the ideal means to improve the micronutrient status of a population ([@B155]). This strategy, however, requires changes in cultural or religious habits of certain communities, as well as recurrent interventions ([@B20]). Fortification includes the administration of micronutrient to the population under the form of pills or fortification of food products (such as flour). The latter method, which is mandatory in many countries, has proven to be a rapid medium to ensure optimal micronutrient levels in the troubled populations ([@B139]; [@B163]; [@B11]; [@B152]; [@B195]). Unfortunately, supplementation depends on specialized infrastructure and appears difficult to implement in poor rural populations who have the highest demand for micronutrient interventions ([@B20]). Luckily, biofortification, which involves the augmentation of the natural nutritional value of crops, can be addressed as a valuable additional strategy in the battle against MNM ([@B20]; [@B66]; [@B121]; [@B178]). Biofortification of locally consumed crops does not require changes in consumer behavior and demands only a one-time investment ([@B46], [@B47]; [@B28]). Biofortification of staple crops, massively consumed in deficient populations, is an excellent way to supply sufficient micronutrients ([@B20]; [@B44]). Biofortification *sensu stricto*, thereby omitting agricultural interventions ([@B30]; [@B197]), comprises breeding techniques as well as genetic engineering approaches ([@B20]; [@B28]). Breeding strategies have the advantage to be easily implemented in agriculture, as they do not require exhaustive regulations ([@B125]). However, the scope of the breeding approaches is confined to sexual compatibility, thereby lacking the ability to exploit useful animal or prokaryotic derived characteristics ([@B178]). Biofortification via metabolic engineering, overrules this restriction. Furthermore, the latter approaches enable creation of a biofortification strategy blue-print, applicable to a wide variety of food crops ([@B178]). Metabolic engineering does, however, require a great knowledge of the specific micronutrient metabolism and its importance in the physiology of the plant.

This review reflects upon the acquired knowledge which enabled successful B-vitamin biofortification in food crops, bundling information on thiamin (B1), pyridoxine (B6), and folates (B9). This evaluation includes vitamin function in plant growth and development as well as importance in human pathophysiology, epidemiology and accomplishments in biofortification. Furthermore, in view of multi-biofortification, the simultaneous biofortification of multiple vitamins and minerals, possible synergistic or adverse effects of micronutrient combinations, are scrutinized. Multi-biofortification endeavors are the step-stone for future eradication of MNM. A list of abbreviations can be found in **Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**.

Vitamin B1 -- Thiamin
=====================

Thiamin is a water soluble B-vitamin consisting of a pyrimidine ring, linked to a thiazole moiety by a methylene bridge ([@B117]) (**Figure [1](#F1){ref-type="fig"}**). Vitamin B1 consists of different itamer forms of thiamin, predominantly occurring as thiamin and its different phosphate esters thiamin pyrophosphate (TPP) and thiamin monophosphate (TMP). However, other forms of thiamin do exist, such as thiamin triphosphate, though their contribution to the total pool is rather marginal ([@B65]). In literature, thiamin(e) is sometimes confusingly used to describe the total pool of the different B1-vitamers, here simply referred to as B1. The bioactive vitamer is TPP, serving as cofactor in multiple enzymatic reactions.

![Thiamin biosynthesis in plants. Synthesis of pyrimidine and thiazole moieties as well as their condensation occurs in plastids. Biosynthesis pathway is shown in blue, enzymes in black. Transport across membranes is proposed to be carrier-mediated (barrels), of which the identified mitochondrial TPP carrier is indicated (red barrel) ([@B63]). The chemical structure of thiamin is depicted, of which the free hydroxyl group can be pyrophosphorylated by action of thiamin pyrophosphokinase (TPK). End product feed-back, performed by TPP on the *THIC* riboswitch, is depicted in red. Products: Gly, glycine; NAD^+^, nicotinamide adenine dinucleotide; SAM, *S*-adenosylmethionine; AIR, 5-aminoimidazole ribonucleotide; HET-P, 4-methyl-5-β-hydroxyethylthiazole phosphate; HMP-P, 4-amino-2-methyl-5-hydroxymethylpyrimidine phosphate; HMP-PP, HMP-pyrophosphate; TMP, thiamin monophosphate; TPP, thiamin pyrophosphate. Enzymes: THIC, HMP-P synthase; THI1, HET-P synthase; TH1, HMP-P kinase/TMP pyrophosphorylase; TPK, thiamin pyrophosphokinase; TH2, TMP phosphatase, PALE GREEN1.](fpls-09-00443-g001){#F1}

Biosynthesis
------------

Biosynthesis of TPP in plants takes place in plastids, cytosol and mitochondria (**Figure [1](#F1){ref-type="fig"}**). Although the TMP vitamer is synthesized in the chloroplast, subsequent enzymatic reactions in mitochondria and cytosol are required to finalize the *de novo* biosynthesis of TPP, the bioactive vitamer ([@B129]; [@B77]; [@B95]). Formation of TMP involves the synthesis of the thiazole and pyrimidine moieties, followed by their condensation, all of which occur in chloroplasts ([@B77]). The thiazole moiety of the thiamin structure is created by the action of 4-methyl-5-β -hydroxyethylthiazole phosphate (HET-P) synthase (THI1), requiring NAD^+^ and glycine as a substrate and yielding HET-P ([@B73]). In this reaction the THI1 enzymes is consumed, as it supplies a sulfide from a cysteine residue, making THI1 a 'suicidal' enzyme. 4-amino-2-methyl-5-hydroxymethylpyrimidine phosphate (HMP-P) synthase (THIC) is an iron-sulfur cluster containing enzyme, catalyzing the formation of HMP-P, the pyrimidine intermediate of thiamin biosynthesis ([@B151]; [@B107]; [@B77]). This reaction requires 5-aminoimidazole ribonucleotide (AIR) (derived from purine metabolism) and *S*-adenosylmethionine (SAM) as substrates ([@B34]). This is the key regulatory step of thiamin biosynthesis, as the promotor is under control of the circadian clock, and the terminator is feedback inhibited by the end product TPP ([@B25]). This terminator contains a riboswitch, rarely seen in eukaryotes ([@B192]). The riboswitch acts by binding TPP in its pre-mRNA state, resulting in the formation of an unstable splice variant of the *THIC* gene, thereby causing a lowered THIC activity ([@B192]; [@B25]). Next, the bifunctional enzyme harboring HMP-P kinase and TMP pyrophosphorylase activities (TH1), catalyzes the HMP-P phosphorylation and subsequent condensation of HMP-PP and HET-P to form TMP ([@B7]). TMP forms the end product of plastidial thiamin biosynthesis and is further processed by the PALE GREEN1/TH2 enzyme, after exiting the plastids ([@B129]; [@B95]). The subcellular localization of TH2 action, being cytosolic, mitochondrial, or both, has been debated. First, the enzyme was discovered in the cytosolic fraction of Arabidopsis ([@B97]; [@B129]). Later experimental evidence, utilizing translational fusions with green fluorescent protein (GFP), confirmed the cytosolic location of the TH2 enzyme, realized from a (preferred) native secondary translational initiation site ([@B129]). This secondary translational initiation site yields a protein which lacks the functional N-terminal mitochondrial targeting peptide of TH2. Therefore, TH2 was considered to be predominantly residing in the cytosol though likely also present in mitochondria. More recently, TH2 was found to be almost exclusively localized in the mitochondria of *th2/pale green1* rescued with a GFP-fused TH2, controlled by the cauliflower mosaic virus (CaMV) 35S promoter ([@B95]). These seemingly contradicting findings can be explained by the fact that a strong constitutive promoter (35S) preceding the full coding sequence of *TH2*, favors the first translational start site and incorporates the mitochondrial targeting peptide into the arising protein ([@B95]). However, these findings highlight the ability of sole mitochondrial TH2 activity to complement the *th2/pale green1* mutant, indirectly hinting at the existence/necessity of a mitochondrial TMP importer as well as a thiamin exporter. Combining these results, it can be concluded that TMP dephosphorylation, executed by TH2, likely occurs primarily in the cytosol and to a lesser extent in mitochondria. However, it cannot be excluded that this subcellular localization of TH2 action might change in different conditions/tissues/species. The reaction mediated by TH2 yields thiamin. In turn, thiamin, is the substrate for thiamin pyrophosphokinase (TPK), producing the active vitamer TPP in the cytosol ([@B6]). TPP subsequently travels to the different subcellular locations via carriers. Two mitochondrial TPP carriers have been partially characterized in plants ([@B63]).

Role in Plant Physiology
------------------------

Vitamin B1, sometimes called the 'energy vitamin,' plays a crucial role in plant energy homeostasis, mostly by the role of TPP as a cofactor ([@B76]). TPP is a cofactor for three enzymes which are central to the energy metabolism. First, the pyruvate dehydrogenase (PDH) complex, catalyzing pyruvate decarboxylation, yielding acetyl CoA and NADH, necessary for the tricarboxylic acid (TCA or Krebs) cycle and biosynthetic processes, respectively ([@B25]). In addition, in the tricarboxylic acid cycle, α-keto-glutarate dehydrogenase (2-oxoglutarate dehydrogenase E1 component, OGDH) functioning also requires TPP, further accentuating its critical role in central metabolism ([@B149]). Third, TPP is an essential cofactor of the transketolase (TK) enzyme, playing a key role in the Calvin cycle as well as the pentose phosphate pathway, which renders pentose sugars as well as NADPH to the cell ([@B76]).

Hence B1, in its form of TPP, controls a few key steps in central aerobic energy metabolism. In this regard, TPP has been suggested to influence the flux through these pathways, as it is required in their rate-limiting steps ([@B25]). Indeed, modestly increasing TPP concentration, through introduction of a non-functional riboswitch in Arabidopsis, induced enlarged activity of TPP-dependent enzymes (PDH, OGDH, and TK) ([@B25]). Moreover, these plants emitted larger amounts of CO~2~, suggesting overactive oxidative metabolism. This is further confirmed by the observation of depleted starch reserves at the beginning of the light period in high TPP lines ([@B25]). This presents a clear rationale behind the strict circadian regulation on B1 biosynthesis. As a consequence of its influence on central metabolism, metabolite composition, particularly that of amino acids, is severely altered in plants with aberrant B1 composition ([@B25]).

B1 metabolism was shown to have a clear function in enabling plants to cope with biotic as well as abiotic stresses. Thiamin biosynthesis as well as B1 levels were observed to increase upon application of abiotic stresses such as high light, drought, salt and oxidative stress, conferring tolerance ([@B102]; [@B202]). Remarkably, this B1-induced tolerance to oxidative stress was concomitant with decreased production of reactive oxygen species (ROS) ([@B184]). The exact molecular basis for this role of B1 in stress adaptation of plants remains partly unknown. Given the enhanced expression of TPP-dependent enzymes in plants exposed to drought stress, the influence of B1 on abiotic stress control seems to be via its end product TPP ([@B149]). On the other hand, the B1 biosynthesis enzyme THI1, responsible for plastidial thiazole biosynthesis, appears to be able to directly regulate stomatal closure ([@B112]). The potential of B1 to enhance abiotic stress tolerance was, however, not observed in engineered Arabidopsis lines ([@B54]). Considering biotic stresses, B1 has been shown to confer systemic acquired resistance (SAR) ([@B3]; [@B12]; [@B27]). Thiamin-treated plants depicted enhanced ROS (hydrogen peroxide, produced upon up-regulation of superoxide dismutase) accumulation upon infection ([@B12]), contrasting their role of decreasing ROS in abiotic stresses ([@B184]; [@B102]). By doing so, thiamin provokes priming, a state in which the plant has the ability to react more rapidly upon infection ([@B40]; [@B3]). This priming effect, described for B1, was confirmed in high B1 engineered Arabidopsis ([@B54]), but not seen in rice ([@B55]). Moreover, thiamin treatment of plants induced higher accumulation of phenolic compounds, salicylic acid (SA) (through higher phenylalanine ammonia lyase activity) and nitrogen assimilation (via increased nitrate reductase activity) ([@B12]).

Pathophysiology and Epidemiology
--------------------------------

The central role of B1 in central (oxidative) metabolism in humans is reflected in its pathophysiology upon vitamin deficiency. TPP plays an indispensable role in energy metabolism as a cofactor in cleavage of α-keto acids ([@B2]), as well as general oxidative metabolism, identical to its role *in planta*. While having lost the ability to synthesize thiamin during their evolution, humans possess the potential to interconvert the different thiamin phosphate-esters ([@B207]; [@B14]).

B1 was the first vitamin for which deficiency was characterized, as it was considered a "vital amine' (hence 'vitamine'), defined as a substance inducing the disease beriberi upon insufficient consumption ([@B117]). Beriberi is a disease occurring upon severe B1 deficiency, divided in wet and dry beriberi, depending on whether it is manifested in the cardiovascular system or in the peripheral nervous system, respectively ([@B1]). B1 deficiency can cause heart problems, and even lead to heart failure ([@B158]). Different symptoms, such as enlarged heart and increased venous pressure, have been reported. B1 deficiency has also been linked to Sudden Infant Death Syndrome (SIDS), due to brainstem malfunctioning related to hypo-oxidative metabolism ([@B118]). An insufficient supply of the B1-vitamin can induce severe alternation of the nervous system, which leads to a disorder called Wernicke's encephalopathy (WE) ([@B99]). WE involves the arising of selective brain lesions, the first symptoms of which include confusion, apathy and impaired awareness, eventually ending in coma and death. B1 deficiency-induced disorders are in many cases easily reverted with thiamin application, and often witnessed in patients suffering from chronic alcoholism ([@B29]). The detrimental effect of B1-deficiency on brain functioning can be explained by the strong dependency of the brain on the oxidative metabolism ([@B29]; [@B71]).

One of the greatest risks of B1-deficiency, along with the lethal consequences of untreated WE, is the difficulty of diagnosis, leaving many illnesses untreated ([@B87]). Although cases of severe beriberi have become rare, outbreaks of B1-deficiency-induced beriberi have been reported on a global scale, causing many deaths, even upon sufficient access to healthcare ([@B119]; [@B4]). Hence, in developing countries, B1-deficiency often is not linked to the observed casualties ([@B15]). Moreover, infantile exposure to B1-deficiency was recently shown to have long-term effects on motor functions and balance of the child ([@B86]). Furthermore, elderly people have been shown to be highly susceptible to B1-deficiency, even in the developed world ([@B93]). Indeed, an investigation in New York state (United States) identified 14% of elderly as being B1-deficient ([@B110]). B1-deficiency is likely to be exacerbating Alzheimer's disease, and could therefore be considered a serious threat, definitely not confined to the developing world ([@B72]).

Good sources of vitamin B1 are, besides animal-derived products (meats, liver, eggs, and dairy products), beans and peas, nuts and whole grains ([@B117]; [@B186]). Different massively consumed crops, such as rice, cassava, potato and plantain contain inadequate amounts of B1 (**Table [1](#T1){ref-type="table"}**). In the case of rice, polishing, which removes the aleurone layer to avoid rancidification, eliminates many nutritionally valuable substances, including B1 ([@B77]). This is illustrated by the original observation of B1-deficiency induced paralysis and death in fowls fed with polished rice, reversible by administration of the rice polishings ([@B117]). Therefore, overconsumption of such staples in a monotonous diet, imposes a serious threat to human health. Furthermore, high carbohydrate intake increases the need of dietary B1, which is explained by its role in carbohydrate catabolism ([@B56]). This emphasizes the need for increased B1 levels in these popular starchy crops.

Biofortification
----------------

Engineering of the thiamin biosynthesis pathway to augment thiamin content in plants has been attempted recently ([@B54], [@B55]). The key step in thiamin -and therefore B1- engineering is the first committed step in plastidial pyrimidine biosynthesis, *THIC* ([@B151]). Activity of the THIC enzyme seems to be a major determinant of B1 biosynthesis, as indicated by the oscillations of the corresponding mRNA transcript with TMP levels ([@B25]). Moreover, this gene harbors a TPP-binding riboswitch in its 3′ UTR, which enables it to destabilize its mRNA upon high TPP prevalence ([@B192]). This feedback mechanism, rather unique in eukaryotes, further highlights THIC as a regulatory point in B1 biosynthesis and therefore the *THIC* gene as an ideal candidate in metabolic engineering approaches ([@B144]). Indeed, eliminating this riboswitch, thereby removing the feedback inhibition on THIC, elevates thiamin level 1.6-fold in Arabidopsis ([@B25]). Enhancing the flux toward biosynthesis of the pyrimidine intermediate is likely insufficient for accumulation of B1. Indeed, feeding Arabidopsis seedlings with the intermediates pyrimidine and thiazole indicates that both are necessary to achieve higher levels of B1 ([@B144]). Combined overexpression of *THIC* and *THI1*, the plastidial thiazole biosynthetic enzyme ([@B73]), further enhanced B1 levels of Arabidopsis over threefold compared to wild type ([@B54]). Similarly, implementation of this combined engineering strategy in rice resulted in B1 increase of 2.5-fold in leaves and 5-fold in unpolished grains ([@B55]). However, B1 levels remained barely affected in polished rice seeds. Future engineering strategies in B1-biofortification will tackle additional bottlenecks in B1-accumulation as well as applying engineering strategies to specific tissues ([@B77]). Taken into account the detrimental effects of *THIC*-riboswitch elimination, resulting in chlorotic plants with enhanced carbohydrate oxidation ([@B25]), B1 biofortification should be approached with caution.

Besides metabolic engineering, there are opportunities to enhance B1 content in crops via breeding techniques. Indeed, several (wild) potato varieties were identified which harbor over 2-fold difference in B1 content compared to popular agricultural potato cultivars ([@B78]). Similarly, up to 2.7-fold variation was found in different cassava accessions ([@B120]). Previously, over 10-fold B1 variation has been measured in rice ([@B103]). Recently, a genome wide association study (GWAS) identified multiple quantitative trait loci (QTL), underlying B1 content in common wheat ([@B113]). These results imply that breeding strategies could help in acquiring higher B1 levels in popular/regional crop varieties. On the other hand, elevating of B1 levels through exposure to certain biological stresses has been suggested, as this proves to augment B1 biosynthesis by significantly increasing the expression of the biosynthesis genes ([@B101]).

Vitamin B6
==========

Vitamin B6 represents a group of water-soluble molecules with similar biochemical properties, consisting of pyridoxine (PN), pyridoxal (PL), pyridoxamine (PM), and their phosphorylated esters ([@B64]). PN, PL and PM differ by carrying a hydroxymethyl, an aldehyde or an aminomethyl substituent, respectively (**Figure [2](#F2){ref-type="fig"}**) ([@B89]). Considering these six vitamers, the phosphorylated pyridoxal (PLP, **Figure [2D](#F2){ref-type="fig"}**) is the most bioactive, functioning as a cofactor in over a hundred reactions ([@B64]). B6 can be considered a powerful antioxidant, comparable to carotenes (vitamin A) and tocopherols (vitamin E), as they are able to quench ROS ([@B17]).

![Chemical structure of different B6 vitamers. **(A)** pyridoxal (PL), **(B)** pyridoxine (PN), **(C)** pyridoxamine (PM), **(D)** pyridoxal-phosphate (PLP), **(E)** pyridoxine-phosphate (PNP), **(F)** pyridoxamine-phosphate (PMP).](fpls-09-00443-g002){#F2}

Biosynthesis
------------

*De novo* biosynthesis of vitamin B6 takes place in the cytosol and comprises only two enzymes (**Figure [3](#F3){ref-type="fig"}**). Pyridoxal phosphate synthase protein (PDX1) generates pyridoxal 5′-phosphate (PLP) utilizing ammonia, glyceraldehyde 3-phosphate (G3P) and ribose 5′-phosphate (R5P) as substrates ([@B182]). This ammonia originates from the reaction catalyzed by the PDX2 glutaminase, which releases ammonia from glutamine to yield glutamate ([@B180]). Furthermore, PMP/PNP oxidase (PDX3) is considered a crucial step in PLP salvage, ensuring its retrieval from the PMP and PNP vitamers ([@B164]). The non-phosphorylated vitamers PL, PM, and PN, can be converted to their corresponding phosphorylated vitamers by the action of the SALT OVERLY SENSITIVE 4 kinase (SOS4) ([@B170]). Finally, a pyridoxal reductase (PLR1) was identified, mediating a NADPH-requiring conversion of PL to PN ([@B90]). Through these reactions plants are capable of balancing the different vitamer forms of B6, which is required to ensure controlled growth and development ([@B37]).

![Vitamin B6 biosynthesis in plants. *De novo* biosynthesis of vitamin B6 is cytosolic. PLP, the major bioactive B6 vitamer is synthesized via consecutive action of PDX2 and PDX1 enzymes. Reactions required to interconvert these different vitamers are depicted. Biosynthesis pathway is shown in blue, enzymes in black. Products: Gln, glutamine; Glu, glutamate; NH~3~, ammonia; R5P, ribose 5′-phosphate; G3P, glyceraldehyde 3-phosphate; PL, pyridoxal; PN, pyridoxine; PM, pyridoxamine; PLP, pyridoxal phosphate; PNP, pyridoxine phosphate; PMP, pyridoxamine phosphate; NADPH, nicotinamide adenine dinucleotide phosphate. Enzymes: PDX1, pyridoxal phosphate synthase protein; PDX2, pyridoxine biosynthesis glutaminase; PDX3, PMP/PNP oxidase; SOS4, SALT OVERLY SENSITIVE4; NSP, non-specific phosphatase; PLR1, pyridoxal reductase.](fpls-09-00443-g003){#F3}

Role in Plant Physiology
------------------------

Vitamin B6 is involved in a plethora of metabolic reactions, serving as cofactor or required as an antioxidant ([@B181]; [@B133]). PLP is considered to function as a cofactor for about 200 enzymatic reactions in Arabidopsis ([@B64]). These PLP-dependent enzymes, covering oxidoreductases, transferases, hydrolases, lyases, and isomerases, can be explored using the B6 database tool ([@B141]). These reactions roughly cover the whole spectrum of plant metabolism. In doing so, B6 is required in amino acid synthesis as well as catabolism ([@B133]). This is illustrated by the Arabidopsis mutant *reduced sugar response (rsr4-1)*, harboring a mutated B6 biosynthesis gene (*PDX1*), exhibiting a decreased content of shikimate, altered levels of different amino acids, and higher levels of TCA constituents (malate, citrate and fumarate) ([@B193]). Similarly, Arabidopsis mutants for the PLP salvage enzyme PDX3 (involved in B6 vitamer interconversions) contained aberrant amino acid profiles. The initial step in starch breakdown, α-glucan phosphorylase, requires PLP as a cofactor ([@B133]). Furthermore, PLP-dependent enzymes play a role in synthesis of glucosinolates ([@B128]). Remarkably, biosynthesis of the plant hormones auxin ([@B208]) and ethylene ([@B187]; [@B190]) as well as ethylene breakdown ([@B135]) involve PLP-requiring enzymes. B6 levels have also been linked to nitrogen metabolism as *pdx3* lines were shown to be ammonium dependent ([@B37]). This link is further strengthened by the observation that the ammonium transporter mutant *amt1* has altered B6 levels ([@B140]).

On top of its vast influence on plant metabolism via PLP-depending enzymes, B6 plays a crucial role as an antioxidant ([@B189]; [@B64]). Arabidopsis mutants with a lowered B6 status, exhibit distinct phenotypes including poor seed development, delayed flowering and reduced plant growth, while complete knock-outs are lethal ([@B189]). The lowered tolerance of these mutants to salt, high light, ultraviolet light, and oxidative stress illustrate the importance of B6 as a stress protector ([@B189]). Upon heat stress, a non-catalytic pyridoxine biosynthesis protein (PDX1.2), ensures sufficient B6 production by aiding its paralogs (PDX1.1 and PDX1.3), resulting in an increase of B6 content ([@B130]; [@B48]). Conversely, Arabidopsis lines, engineered for enhanced B6 content, display enhanced tolerance to abiotic stresses ([@B150]). Furthermore, these plants exhibit enlarged cells, leading to larger organs. Interestingly, their amino acid and sugar composition is severely altered, reflecting the broad influence of B6 on plant metabolism.

Pathophysiology and Epidemiology
--------------------------------

Vitamin B6, especially PLP, is crucial for correct human functioning, as it is required as a cofactor for around 4% of all enzyme activities ([@B185]). Most of these reactions involve amino acid synthesis and catabolism, in which PLP serves as a cofactor in transaminations, aldol cleavages and carboxylations. Furthermore, PLP plays a role in energy metabolism as it is involved in gluconeogenesis and lipid metabolism. Moreover, B6 is necessary in the biosynthesis of heme as well as neurotransmitters ([@B185]). In addition, B6 plays an important role as an antioxidant ([@B100]) and is even known to aid in enzyme folding ([@B33]).

In parallel with its functions in human metabolism, B6 deficiency is manifested in a broad spectrum of disorders. Most notably, B6 deficiency is known to provoke neurological disorders, such as peripheral neuropathy ([@B70]) and epileptic seizures ([@B172]). Moreover, B6 deficiency might be linked to anemia, given the ability of B6 intake to cure some cases of the disease ([@B92]). Furthermore, B6 deficiency has been associated with cardiovascular diseases, stroke, rheumatoid arthritis, diabetes and different types of cancer including colorectal, lung, breast, and kidney ([@B185]).

Although investigation on vitamin B6 deficiency on a global scale is lacking, there is evidence supporting the existence of persistent deficiency in several populations ([@B64]). Indeed, studies in the United States and South Korea concluded that around one-in-four people have sub-optimal B6 status ([@B142]; [@B105]). Furthermore, half of the elderly in nursing homes in Norway were considered B6 deficient ([@B106]). The situation in developing countries is estimated to be even worse, given the observation that over half of the population of Uganda and Sudan remain B6 deficient ([@B64]). Knowing the detrimental effect this deficiency, remaining undiagnosed, could exert on human health, there is a strong need to supply these people with satisfactory amounts of B6.

Humans, unable to synthesize B6 *de novo*, predominantly depend on their diet for sufficient B6 acquisition, as gut bacteria can be considered as suppliers of marginal amounts of different vitamins ([@B109]; [@B64]). Good sources of dietary B6, besides animal-derived products such as fish and meat, are fresh vegetables including carrots and onions ([@B186]; [@B64]). However, bioavailability should be considered, given the observations that up to half of the B6 pool could be lost as a result of incomplete digestibility, which is found to be more problematic in plant-based food sources compared to animal products ([@B159]). Furthermore, the most consumed staple crops in the world are considered poor sources of dietary B6 ([@B64]) (**Table [1](#T1){ref-type="table"}**).

Biofortification
----------------

Metabolic engineering approaches rely on the knowledge acquired of the relatively simple plant B6 biosynthesis pathway, mainly involving PDX2 ([@B180]) and the pyridoxal phosphate synthase protein (PDX1) ([@B182]). In a metabolic engineering strategy, overexpression of both *PDX1* and *PDX2* genes yielded up to fourfold increase in B6 levels, while overexpression of the single genes only generated marginal effects ([@B150]). Interestingly, enhanced plant biomass in aerial organs with similar overall morphology as well as tolerance to oxidative stress were observed in two-gene engineered plants with increased B6 content. When targeted to roots, the two-gene approach, enabled almost sixfold augmentation of B6 in cassava, without any severe alteration in yield ([@B114]). The success of this two-gene engineering strategy therefore supports assessment in different crops, as well as investigation of possible influences on crop physiology and yield.

So far, analysis of crop germplasm has revealed limited variation (\<2-fold) in B6 composition of potato ([@B132]) and wheat ([@B169]). However, screening of vast accessions of a particular crop could identify interesting lines and thereby also pinpoint novel important QTLs and maybe novel genes influencing B6 homeostasis ([@B64]).

Vitamin B9
==========

Folate is a collective term for a group of water soluble B9 vitamins. Folates can be considered tri-partite structures, consisting of a pterin ring linked to the *para*-aminobenzoate (*p*-ABA) moiety carrying a γ-linked glutamate tail ([@B165]; [@B154]) (**Figure [4](#F4){ref-type="fig"}**). The different folate species, called vitamers, are chemically different on three levels, being the oxidation state, the glutamate tail length and the nature of C1-substituents ([@B21]; [@B178]). These properties all exert an influence on folate stability. First, oxidized folates are considered more stable, given the susceptibility of the pterin -- *p-*ABA linkage to (photo-) oxidative cleavage ([@B21]). Tetrahydrofolates (THF), the most reduced folate forms, harboring a fully reduced B-ring in the pterin moiety, are the active cofactors. Conversely, folic acid, containing an aromatic pterin B-ring, is more stable, though exhibiting marginal natural occurrence ([@B21]; [@B75]). In this respect, the term 'folic acid' is used to indicate the synthetic folate analog. Second, folate entities greatly differ in their glutamate tail length, as they carry one to eight glutamates ([@B67]; [@B178]). Polyglutamylated folates are thought to possess enhanced *in vivo* stability as their polyglutamate tail ensures cellular retention as well as augmented association with folate dependent enzymes ([@B19]). Third, folates species can differ in their attached C1- units, giving rise to an array of folate entities, affecting their stability and biological role (**Figure [4](#F4){ref-type="fig"}**).

![Chemical structure of folates (B9). The three different folate components, pterin (green), para-aminobenzoate (blue), and glutamate tail (red) are indicated. Here, a fully reduced tetrahydrofolate (THF) is presented. Figure adopted from ([@B178]).](fpls-09-00443-g004){#F4}

Biosynthesis
------------

In plants, folate biosynthesis is executed in different subcellular localizations (**Figure [5](#F5){ref-type="fig"}**). The pterin 'branch' resides in the cytosol ([@B178]). Here, the first committed step is executed by GTP cyclohydrolase I (GTPCHI), utilizing GTP as a substrate and yielding 6-hydroxymethyldihydropterin (HMDHP) ([@B16]). An alleged pterin mitochondrial importer is considered to ensure translocation of HMDHP to the mitochondrion ([@B85]; [@B178]). The plastidial *p*-ABA branch supplies the *p*-ABA moiety of the folate molecule (**Figure [5](#F5){ref-type="fig"}**). Here, the first committed step is performed by aminodeoxychorismate synthase (ADCS), using chorismate, originating from the shikimate pathway ([@B91]), as a substrate ([@B161]). Given the hydrophobic nature of *p*-ABA, it is thought to reach the mitochondria by diffusion through membranes ([@B85]; [@B178]). Upon entering the mitochondria, HMDHP is pyrophosphorylated and coupled with *p*-ABA to form dihydropteroate. These enzymatic reactions are executed by the bifunctional HMDHP pyrophosphokinase/dihydropteroate synthase (HPPK/DHPS) ([@B74]). Subsequently, dihydropteroate is converted to dihydrofolate (DHF) by the action of dihydrofolate synthetase (DHFS) ([@B153]), followed by a reduction catalyzed by dihydrofolate reductase as part of a bifunctional enzyme dihydrofolate reductase/thymidylate synthase (DHFR-TS) ([@B75]), yielding THF. Folate biosynthesis is finalized upon polyglutamylation of THF, by the action of folylpolyglutamate synthetase (FPGS) ([@B153]; [@B124]).

![Folate biosynthesis is plants. Folate (vitamin B9) biosynthesis in plants occurs in three subcellular compartments: the cytosol, the plastids (green) and the mitochondrion (red). Biosynthesis pathway is shown in blue, enzymes in black. Polyglutamylated folates are considered the end product of folate biosynthesis. Products: ADC, aminodeoxychorismate; *p*-ABA, *para*-aminobenzoate; DHN-P~3~, dihydroneopterin triphosphate; DHN-P, dihydroneopterin monophosphate; DHN, dihydroneopterin; HMDHP, 6-hydroxymethyldihydropterin; HMDHP-P2, HMDHP pyrophosphate; DHP, dihydropteroate; DHF, dihydrofolate; Glu, glutamate; THF, tetrahydrofolate. Enzymes: ADCS, ADC synthase; ADCL, ADC lyase; GTPCHI, GTP cyclohydrolase I; DHNTPPH, dihydroneopterin triphosphate pyrophophohydrolase; NSP, non-specific phosphatase; DHNA, DHN aldolase; HPPK, HMDHP pyrophosphokinase; DHPS, DHP synthase; DHFS, DHF synthetase; DHFR, DHF reductase; FPGS, folylpolyglutamate synthetase.](fpls-09-00443-g005){#F5}

Role in Plant Physiology
------------------------

The chemical structure of folates makes them ideal carriers of C~1~-substituents, conferring a central role in carbon metabolism of nearly all living organisms ([@B21]), with the exception of some Archaea ([@B75]). Thereby, folates are both needed for proper anabolism as well as catabolism of cellular compounds. They play an essential role in the synthesis of purines as well as thymidylate and are therefore indispensable in DNA synthesis and growth ([@B177]). Furthermore, folates are required in biosynthesis of many plant metabolites including pantothenate (vitamin B5) and formyl methionyl tRNA as well as serine and glycine interconversion and catabolism of histidine ([@B21]). Furthermore, folates are needed in production of lignin, ensuring cell wall rigidity ([@B173]). In addition, iron-sulfur cluster enzymes depend on folates for their assembly ([@B194]). Given their role as C1 donors and acceptors, folates play a key role in the methyl cycle ([@B21]). 5-methyl-THF, is required as a methyl-donor in the conversion of homocysteine to methionine, which is necessary for replenishing of the SAM-pool ([@B21]). SAM in its turn, functions as methyl storage in supplying this C~1~-unit to a wide range of methyltransferases, including DNA methyltransferases. Therefore, insufficient folate can alter the methyl-cycle homeostasis and evoke epigenetic changes by alteration in the DNA methylation pattern ([@B209]). A disequilibrated folate homeostasis greatly influences epigenetic functioning through genome-wide hypomethylation, lowered histone methylation and transposon derepression, as witnessed in Arabidopsis methyleneTHF dehydrogenase/methenylTHF cyclohydrolase (*MTHFD1*) mutants ([@B80]). Similarly, aberrant functioning of FPGS, the enzyme responsible for extension of the glutamate tail, evoked upregulation of transposable elements (typically repressed by methylation), which could be reverted via administration of 5-methyl-THF ([@B209]).

Additional to their requirement in catabolism and anabolism of essential plant metabolites, folates appear to have a profound influence on plant growth and development. In non-photosynthetic plastids, the plastidial pool of folates influences plant energy metabolism by inhibiting starch formation ([@B88]). The mechanism is thought to operate via depletion of the ATP pool -required in starch assembly from sucrose- upon folate shortage, regulated by the folate-dependent DHFR-TS ([@B88]). Remarkably, the interplay of folate and sugar metabolism was shown to modulate auxin signaling, hence controlling plant development ([@B174]). Moreover, folates possess the ability to influence seed composition, demonstrated by the high N-content of Arabidopsis plastidial FPGS (*atdfb-3*) loss-of-function mutant seeds ([@B126]). This reveals an interaction between folate metabolism and N-metabolism in darkness. Folate metabolism was also shown to maintain root development in the indeterminate state, via FPGS functioning ([@B156]). Folate synthesis and therefore accumulation is high during germination and in meristematic tissues, coherent with their demand upon cell division and concomitant DNA synthesis ([@B154]). Moreover, folate biosynthesis is stimulated upon light exposure, indicating a higher folate requirement ([@B154]). Indeed, the production of chlorophyll is dependent on folate ([@B188]). Moreover, folates are able to ensure sufficient NADPH production, thereby controlling cellular redox state by a balanced functioning of *DHFR-TS* genes, needed in detoxification of ROS originating from photosynthesis or photorespiration ([@B75]). In photorespiration, folate is directly required as a cofactor for the serine hydroxymethyltransferase in the glycine decarboxylase complex ([@B38]; [@B123]). Finally, folate biosynthesis enzymes are known to influence plant stress responses, possibly through generation of folate biosynthesis intermediates ([@B176]; [@B136]).

Given the influence of folates on plant development, their homeostasis and accumulation is considered to be tightly regulated, depending on their tissue specific requirement ([@B154]). Indeed, recent insights in folate metabolism of Arabidopsis confirm fine-tuning of folate accumulation by feed-back inhibition of a regulatory DHFR-TS homolog (DHFR-TS3) ([@B75]). Together, these findings raise caution toward possible implications upon folate biofortification, as an increased folate pool might influence different aspects of plant physiology ([@B188]).

Pathophysiology and Epidemiology
--------------------------------

Humans lack the ability to synthetize folates *de novo*. However, they possess DHFR and FPGS enzymes, thereby allowing conversion of DHF to THF and polyglutamylated folates, respectively ([@B122]; [@B68]). Hence, humans are almost completely reliant on their diet for adequate folate supply, given that the gut microbiome has a marginal contribution to the folate pool ([@B32]; [@B109]). As the usage of folates as C1 donors and acceptors originated early in evolution, being implemented by prokaryotes and all eukaryotes, their basic functioning in plants is very similar to that in humans. Thus, folates are important in DNA synthesis and in supplying methyl groups to proteins, lipids, and DNA, through their necessity in SAM replenishment ([@B162]). Similar to plants, changes in folates levels have the potency to change the human epigenome ([@B18]). Folates are required in methylation of myelin basic protein, which is pivotal for the compaction of myelin around the neuron sheath, thereby ensuring sufficient nerve conduction ([@B147]; [@B26]).

Upon inadequate dietary folate intake, folate status can drop, a condition known as folate deficiency, which has a broad pathophysiology. Folate deficiency results in decreased erythrocyte development, causing megaloblastic anemia ([@B108]). The elevated levels of homocysteine, resulting from low folate status, can induce vascular diseases, such as coronary artery disease and strokes ([@B10]; [@B81]; [@B206]). The most notable consequence of folate deficiency is its detrimental impact on neurulation. This is revealed by the occurrence of neural tube defects (NTDs) such as *spina bifida*, encephalocele and anencephaly, caused by folate deficiency ([@B69]; [@B203]; [@B79]). Last but not least, different forms of cancer have been linked to inadequate folate status, including colorectal ([@B60]), prostate ([@B145]), and pancreatic tumors ([@B201]).

Folate deficiency is still a global problem, predominantly present in the developing world, yet persisting in many populations of the developed world as well ([@B19]; [@B204]). Moreover, even populations blessed by the availability and opportunity of a diverse and folate-rich diet, remain susceptible to deficiency, as illustrated by the low folate status measured in the Swedish population ([@B58]; [@B83]) and the observed sub-optimal folate levels in 39% of Belgian first trimester pregnancies ([@B191]). Worldwide, 300,000 pregnancies are estimated to be affected by NTDs annually, half of which are considered to be caused by insufficient maternal folate status ([@B61]). China, inhabited by almost 1.4 billion people, recorded a countrywide prevalence of NTDs as high as 0.24% ([@B19]). More strikingly, Shanxi province, located in Northern China, has amongst the highest incidence rates of NTDs in the world, as high as 1.39% ([@B115]).

Fortunately, noteworthy advances have been made in the fight against folate malnutrition. Educational efforts, advocating a diverse diet containing folate rich foods such as green leafy vegetables and fermented products, is the primary strategy to diminish folate deficiency ([@B178]). Folic acid, the synthetic form of folate as administered in pills, has been implemented in fortification strategies, which have ensured a significant reduction of neural tube defects ([@B199]; [@B195]). Unfortunately, high folic acid intake can also impose unwanted side effects, since excessive accumulation of unmetabolized folic acid has been linked to colorectal cancer and impaired immunity ([@B35]; [@B167]). Moreover, both folic acid fortification and supplementation are costly interventions, which are difficult to implement in poor rural regions in need ([@B19]). Therefore, biofortification, via metabolic engineering or breeding is advised to ensure a stable cost-effective means to fight folate deficiency ([@B45], [@B46]; [@B19]; [@B178]).

Biofortification
----------------

Over the last decades, many successful folate biofortification approaches have been conducted, thereby additionally acquiring new insights in folate metabolism in certain crops and tissues ([@B44]; [@B178]). The most widely attempted folate metabolic engineering approach is the enhancement of GTPCHI activity, proven to be a fruitful strategy in prokaryotes ([@B179]). This approach has been confirmed to be functional in plants by the engineering of *cis*-genic Arabidopsis lines, over-expressing *GTPCHI* ([@B94]). This single gene approach, introducing *GTPCHI*, referred to as G-engineering, has been implemented in rice ([@B175]), tomato ([@B42]), maize ([@B134]), lettuce ([@B137]), potato ([@B22]), and Mexican common bean ([@B148]). The highest fold enhancement, reached in the edible portions of these crops is a ninefold folate increase in lettuce. This could possibly be due to a difference in regulation in leafy tissue. However, single gene approaches have hitherto not resulted in over 10-fold increase in folate content. A bigenic approach was substantially more successful, adding ectopic expression of aminodeoxychorismate synthase (ADCS) (GA-strategy). In tomato ([@B43]) and rice ([@B175]) this led to 25- and 100-fold folate enhancement, respectively. Unfortunately, this approach, able to reach the desired levels in tomato and rice, does not promise to be universally applicable, as it only resulted in limited enhancements in Arabidopsis and potato ([@B22]). In rice seeds, ADCS has been indicated as the most important limiting factor in folate biosynthesis, additional to GTPCHI ([@B51]). Building further on these findings, novel biofortification approaches aimed at further gene stacking, using mitochondrial folate biosynthesis genes ([@B178]). Indeed, additional introduction of *FPGS* in GA-engineered plants did not only result in elevated folate levels in rice endosperm (100-fold) and potato tubers (12-fold) respectively, but also in enhanced folate stability upon storage ([@B24]; [@B44]). Increasing storage stability has also been addressed by introduction of mammalian folate binding proteins ([@B24]). This strategy is promising, as it could limit the aforementioned undesired effects of folate increase on plant physiology, via sequestration of the active folate pool. Moreover, recent discovery of plant folate binding proteins creates novel opportunities in folate biofortification via metabolic engineering ([@B146]).

Breeding endeavors, aimed at acquiring elite crop variants with augmented folate content in the edible portion, though not implemented so far, have shown to be feasible ([@B9]; [@B28]). Upon availability of high throughput folate quantification in the food matrix, screening of vast germplasm collections could lead to identification of high folate varieties ([@B41]; [@B178]). In this respect, over sevenfold variation in milled rice folate content was described by examination of 78 accessions ([@B53]). More recently, unpolished brown rice folate content was found to vary up to threefold in 150 examined accessions ([@B5]). Similar screening has been employed in barley ([@B8]), red beet ([@B196]), potato ([@B78]; [@B157]), tomato ([@B96]), muskmelon ([@B111]), common bean ([@B104]; [@B98]), lentil ([@B98]), (chick)pea ([@B98]), spinach ([@B171]), and strawberry ([@B127]). Furthermore, these variations could be utilized to identify interesting QTLs, underlying folate content, in GWAS ([@B104]; [@B52]). These techniques, though limited in their potential folate enhancement, are promising, as they might face lower regulatory restrictions, hence allow more rapid implementation in agriculture, reaching the populations in need ([@B125]; [@B143]).

B-Vitamin Interplay
===================

Multi-biofortification is considered an important goal in the fight against MNM ([@B19]; [@B178]). However, possible effects of altered micronutrient levels upon each other as well as on basic plant growth and development, should be taken into consideration. Examination of the role of B-vitamins in plant metabolism evidently reveals that inducing their accumulation could alter plant physiology. This has been conspicuously observed in metabolic engineering approaches of B1 ([@B25]; [@B54]) and B6 ([@B150]). Furthermore, B9 enhancement, though not depicting any severe effect on plant growth, has shown to alter the rice seed metabolism ([@B23]). The influence of B-vitamins on plant metabolism is, however, at least partly intertwined, indicating the importance of detailed investigation of the effect of their combined biofortification (**Figure [6](#F6){ref-type="fig"}**).

![B-vitamin interplay *in planta*. Different interactions of vitamin B1 \[via thiamin pyrophosphate (TPP) functioning\], B6 \[via pyridoxal phosphate (PLP) functioning\] and B9 (folates) are schematically displayed. Well-established links are indicated in black, potential interactions are indicated in blue. TCA, tricarboxylic acid cycle; PPP, pentose phosphate pathway; G3P, glyceraldehyde 3-phosphate; R5P, ribose 5′-phosphate; SAM, *S*-adenosylmethionine; AIR, 5-aminoimidazole ribonucleotide; NADPH, nicotinamide adenine dinucleotide phosphate.](fpls-09-00443-g006){#F6}

In central energy metabolism, both folate and B1 appear to negatively influence the plant's ability to accumulate starch ([@B25]; [@B88]). PLP (B6) is also involved in starch breakdown, though there are no indications to suspect increased starch breakdown upon elevation of PLP levels ([@B205]; [@B133]). In the biosynthesis of B6, G3P, an intermediate in central energy metabolism (glycolysis), serves as a substrate ([@B64]), the steady state concentration of which might be altered in B1 engineered lines ([@B25]). In altering this central metabolism equilibrium, B1 augmentation might influence the flux through the shikimate pathway ([@B25]), the activity of which is required in the plastidial part of folate biosynthesis ([@B178]). In this shikimate pathway, PLP (B6) is required as cofactor. Folates are able to generate NADPH ([@B75]), replenish the SAM pool ([@B21]), and are needed in the biosynthesis of iron sulfur cluster enzymes ([@B194]). Interestingly, THIC, pinpointed as the rate limiting step in B1 biosynthesis, contains an iron-sulfur cluster and requires SAM for its catalytic activity ([@B144]). Strongly increased THIC activity would therefore require enhanced SAM turnover ([@B138]), for which enhanced folate levels might have a beneficial effect. NADPH is on the other hand required for pyridoxal reductase activity in B6 homeostasis. Ribose 5′-phosphate, an important substrate in B6 biosynthesis ([@B64]), is a product of the pentose phosphate pathway, the flux of which might be controlled by B1 ([@B25]). Similarly, AIR, an important substrate in B1 biosynthesis ([@B144]), is derived from purine metabolism, the synthesis of which is dependent on folate ([@B178]). Moreover, B1, B6, and B9 have been linked to nitrogen metabolism. First, thiamin application is known to stimulate nitrogen assimilation ([@B12]). Second, B6 content was observed to be altered in the ammonium transporter *mutant amt1* ([@B140]). Moreover, PLP (B6) salvage mutant *pdx3* is depending on ammonium ([@B37]). Third, folate biosynthesis mutants (*atdfb-3*, plastidial FPGS) harbored enhanced nitrogen content of seeds ([@B126]). Remarkably, given the labile nature of folate, increasing *in planta* stabilization of folates has been the subject of biofortification strategies ([@B24]). Therefore, enhancing levels of antioxidants, such as B6, has been proposed as an additional biofortification strategy, protecting the folate pool from oxidative cleavage ([@B19]).

Final Remarks
=============

Creation and evaluation of multi-biofortified crops would not only offer a sustainable solution to eradicate MNM, but also help to elucidate the interplay of different micronutrients. The availability of novel tools, allowing facilitated cloning of multiple genes paved the way toward such multi-biofortification ([@B57]). Furthermore, a prerequisite in biofortification strategies is to consider stability upon storage of the crop product, as well as after food processing and bioavailability upon human consumption ([@B24]; [@B50]). Different agronomical techniques could be employed, alone or in combination, to augment vitamin content of crops. Metabolic engineering of the complete pathway, or symbiosis with bacteria, might be appropriate ways to tackle vitamin B12 deficiency ([@B49]). Metabolic engineering strategies could be developed in a precise way, enabling the creation of food crops which harbor an ideal balance of energy supply and micronutrient delivery, while exhibiting marginal effects on plant physiology. These novel crop varieties could, in combination with fortification and dietary interventions eradicate MNM, alleviating a great global burden.
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